Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Carter

Showing results (1001-1010 of 1,023) with videos related to

Pageof 103
Sort By:
Cancer Immunology, Immunotherapy : CII|April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancerKyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Nature Communications|January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomasXin Hu, Marcos R Estecio, Runzhe Chen, et al.
Scientific Reports|July 8, 2022
Prospective cohort study reveals unexpected aetiologies of livestock abortion in northern TanzaniaKate M Thomas, Tito Kibona, John R Claxton, et al.
Journal of Medicinal Chemistry|August 24, 2000
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulatorS W Djuric, N Y BaMaung, A Basha, et al.
BMJ Global Health|October 23, 2024
Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trialCharles J Gerardo, Rebecca W Carter, Surendra Kumar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trialRoshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Nature Communications|February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancerLingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Nature Communications|July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLCMaliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Cancer Discovery|July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 BlockadeLimo Chen, Lixia Diao, Yongbin Yang, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
A Complete Genome for the Common MarmosetPrajna Hebbar, Tamara Potapova, Hailey Loucks, et al.
Pageof 103

Showing results (1001-1010 of 1,023) with videos related to

Sort By:
Pageof 103
Cancer Immunology, Immunotherapy : CII|April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancerKyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Nature Communications|January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomasXin Hu, Marcos R Estecio, Runzhe Chen, et al.
Scientific Reports|July 8, 2022
Prospective cohort study reveals unexpected aetiologies of livestock abortion in northern TanzaniaKate M Thomas, Tito Kibona, John R Claxton, et al.
Journal of Medicinal Chemistry|August 24, 2000
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulatorS W Djuric, N Y BaMaung, A Basha, et al.
BMJ Global Health|October 23, 2024
Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trialCharles J Gerardo, Rebecca W Carter, Surendra Kumar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trialRoshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Nature Communications|February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancerLingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Nature Communications|July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLCMaliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Cancer Discovery|July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 BlockadeLimo Chen, Lixia Diao, Yongbin Yang, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
A Complete Genome for the Common MarmosetPrajna Hebbar, Tamara Potapova, Hailey Loucks, et al.
Pageof 103